Physician profile
Jay Stine
NPI 1982705042
$3,232.49
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $851 · 2021: $1,132 · 2022: $427.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $553.43 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $406.51 | 2019-2022 | |
| Glaxosmithkline, LLC. | $383.52 | 2019-2022 | |
| Amarin Pharma, INC. | $275.85 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $271.75 | 2019-2022 | |
| Lilly USA, LLC | $197.15 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $124.07 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.90 | 2021-2022 | |
| Abbvie INC. | $111.30 | 2021-2022 | |
| Mylan Specialty L.P. | $111.11 | 2020-2021 | |
| Medtronic Vascular, INC. | $102.51 | 2020 | |
| Allergan, INC. | $80.94 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.07 | 2019-2022 | |
| Pfizer INC. | $76.91 | 2019-2021 | |
| Astellas Pharma US INC | $76.63 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $68.07 | 2019-2021 | |
| Esperion Therapeutics, INC. | $62.16 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $52.79 | 2019 | |
| Dexcom, INC. | $33.47 | 2021 | |
| Merck Sharp & Dohme LLC | $15.37 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Nevro Corp. | $13.98 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Stine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.